Guang Zhou Ri Bao·2025-05-16 14:29Group 1 - The increasing focus on women's health is highlighted by initiatives such as the "Healthy China 2030" plan and the "China Women's Development Outline (2021-2030)", which aim to address health issues for key demographics including women and children [1] - Meituan Health has launched the "She Health" public welfare program, which aims to provide comprehensive health services for women, focusing on menstrual health, reproductive health, and nutritional health [2] - Abbott has introduced the "Women’s Menstrual Health Alliance Initiative" to promote menstrual health awareness and improve women's screening and treatment knowledge, while also supporting menopause clinic development [3] Group 2 - Meituan Health reports that over one million women seek health services daily through its online platform, with menstrual pain, gynecological disease treatment, and menopause management being the most common concerns [2] - Abbott's new drug, Fenruining, is designed to treat estrogen deficiency symptoms in postmenopausal women and has entered the Chinese market, indicating Abbott's commitment to the local market [3]